Uloric works by blocking an enzyme called xanthine oxidase, which helps prevent uric acid production, lowering elevated uric acid levels, according to Takeda. In simple terms, sexual problems in.

Uloric, taken once daily by mouth, is approved for the chronic management of hyperuricemia (elevated levels of uric acid) in gout patients. Male Sexual Problems and Treatments Sexual problems are fairly com in men and in most cases these can be easily treated. The new study found no more deaths and no more heart problems in patients taking Uloric than in patients taking allopurinol. The most commonly reported adverse events in Uloric's clinical trials were liver function abnormalities, nausea, joint pain, and rash, according to Takeda Pharmaceuticals. As people with gout problems already are at higher risk of heart disease, the FDA issued an "approvable" letter, noting that Uloric could be approved if this safety question were addressed. The FDA often follows the recommendations of its advisory committees, but it's not obligated to do so.

Takeda resolved the safety question by performing a large new phase III clinical trial that enrolled more gout patients than the two previous phase III trials combined. Based on those results, an FDA advisory committee recommended Uloric's approval in November 2008.

In 2005, the FDA refused to approve Uloric because there were slightly more deaths and heart problems in patients taking the drug than in patients taking allopurinol, another gout drug.